Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) P/E ratio
As of 5 November 2026, Chemed Corporation (CHE) trades at a P/E ratio of 25.5×. Over the past ten years it has ranged from 17.5× (January 2015) to 52.7× (December 2017); the current reading is higher than 39% of that period. That is above the Medical Care Facilities industry median of 17.4× and in line with the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 23.2× | (11.93%) |
| FY2024 | 26.3× | (18.51%) |
| FY2023 | 32.3× | 6.59% |
| FY2022 | 30.3× | (1.66%) |
| FY2021 | 30.8× | 15.94% |
| FY2020 | 26.6× | (16.70%) |
| FY2019 | 31.9× | 44.24% |
| FY2018 | 22.1× | (45.25%) |
| FY2017 | 40.4× | 65.82% |
| FY2016 | 24.4× | 6.43% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 24.1× | 3.12% |
| Jun 2026 | 23.4× | 13.77% |
| Mar 2026 | 20.5× | (11.43%) |
| Dec 2025 | 23.2× | (1.33%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| UHS Universal Health Services, Inc. compare | 8.2× |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 12.6× |
| DVA DaVita Inc. compare | 14.0× |
| OPCH Option Care Health, Inc. compare | 22.6× |
| CON Concentra Group Holdings Parent, Inc. compare | 24.9× |
| CHE Chemed Corporation | 25.5× |
| ENSG The Ensign Group, Inc. compare | 26.3× |
| PACS PACS Group, Inc. compare | 28.6× |
| LFST LifeStance Health Group, Inc. compare | 70.7× |
| Medical Care Facilities industry median | 17.4× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CHE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement